# TRAnexamic Acid for Preventing Postpartum Hemorrhage Following a Cesarean Delivery

> **NCT03431805** · PHASE3 · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 4574 (actual)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** Tranexamic Acid Injectable Solution
- **DRUG:** Sodium Chloride 0.9%

## Key facts

- **NCT ID:** NCT03431805
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-03
- **Primary completion:** 2020-01-14
- **Final completion:** 2020-04-08
- **Target enrollment:** 4574 (ACTUAL)
- **Last updated:** 2026-05-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03431805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03431805, "TRAnexamic Acid for Preventing Postpartum Hemorrhage Following a Cesarean Delivery". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT03431805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*